Zhen Chen

7PUBLICATIONS

16CO-AUTHORS

Molecular targetsMolecular medicineCancer diagnosisTraditional Chinese medicine and treatmentsPredictive and prognostic markers

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (7)

Sort by Publication Date:

|Jul 09, 2026

Luteolin Triggers Pyroptosis in Pancreatic Ductal Adenocarcinoma by Inhibiting Mitochondrial Fission through the RAS/ERK/DRP1 Pathway.

|Oct 08, 2025

Modified Sijunzi Decoction Inhibits Pancreatic Cancer Progression and Improves Immune Suppression: Network Pharmacology and Experimental Validation.

Yuan Zhang, Linjie Ruan, Xin Li

|Oct 03, 2025

Identification of Syndrome Types in Patients With Pancreatic Cancer From Free Text in Electronic Medical Records: Model Development and Validation.

He Ba, Haojie Du, Chienshan Cheng

|Apr 04, 2023

Paired protein kinases PRKCI-RIPK2 promote pancreatic cancer growth and metastasis via enhancing NF-κB/JNK/ERK phosphorylation.

Juying Jiao, Linjie Ruan, Chien-Shan Cheng

|Jun 20, 2022

Evidence-Based Dampness-Heat ZHENG (Syndrome) in Cancer: Current Progress toward Establishing Relevant Animal Model with Pancreatic Tumor.

Ju-Ying Jiao, Chien-Shan Cheng, Zhang-Qi Cao

|Jun 11, 2020

Albumin-to-alkaline phosphatase ratio serves as a prognostic indicator in unresectable pancreatic ductal adenocarcinoma: a propensity score matching analysis.

Ke Zhang, Shu Dong, Yan-Hua Jing

Pageof 2

Frequent Collaborators

Yuan Zhang

Chienshan Cheng

He Ba

Waimei Si

Linjie Ruan

LianYu Chen

Ye Li

ZhiQiang Meng

LuMing Liu

HaiFeng Chen

Frequent Collaborators

Yuan Zhang

Chienshan Cheng

He Ba

Waimei Si